Aberrant Expression of and Cell Death Induction by Engagement of the MHC-II Chaperone CD74 in Anaplastic Large Cell Lymphoma (ALCL).

ALK translocation CD74 MHC-II T cell lymphoma invariant chain

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
07 Oct 2021
Historique:
received: 14 09 2021
accepted: 23 09 2021
entrez: 13 10 2021
pubmed: 14 10 2021
medline: 14 10 2021
Statut: epublish

Résumé

In 50-60% of cases, systemic anaplastic large cell lymphoma (ALCL) is characterized by the t(2;5)(p23;q35) or one of its variants, considered to be causative for anaplastic lymphoma kinase (ALK)-positive (ALK

Identifiants

pubmed: 34638496
pii: cancers13195012
doi: 10.3390/cancers13195012
pmc: PMC8507667
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : MA 3313/2-1 and JA 1847/2-1
Organisme : Berliner Krebsgesellschaft
ID : MAFF-2012-29
Organisme : European Union´s Horizon 2020
ID : Marie Sklodowska-Curie grant No 675712

Références

Arthritis Res Ther. 2012 Mar 09;14(2):R54
pubmed: 22404985
Crit Rev Oncol Hematol. 2012 Aug;83(2):293-302
pubmed: 22440390
Immunity. 2006 Oct;25(4):595-606
pubmed: 17045821
Lung Cancer. 2015 Feb;87(2):89-95
pubmed: 25576294
J Immunol. 1984 Apr;132(4):1900-5
pubmed: 6199417
Mol Cell Proteomics. 2012 Nov;11(11):1457-67
pubmed: 22942358
Virchows Arch A Pathol Anat Histopathol. 1988;412(4):315-22
pubmed: 3125670
Immunology. 1993 Jun;79(2):331-5
pubmed: 8344710
Cancer Res. 1989 Aug 15;49(16):4568-77
pubmed: 2663143
Cancer Cell. 2015 Apr 13;27(4):516-32
pubmed: 25873174
J Biol Chem. 2001 Jul 20;276(29):27203-6
pubmed: 11371575
Br J Haematol. 2015 Jun;169(5):701-10
pubmed: 25847298
Blood. 1989 Sep;74(4):1448-50
pubmed: 2765668
Blood. 2007 Dec 15;110(13):4303-11
pubmed: 17846227
Haematologica. 2010 Mar;95(3):449-55
pubmed: 19951975
Blood. 2000 Dec 1;96(12):3681-95
pubmed: 11090048
Blood. 2014 Aug 28;124(9):1473-80
pubmed: 24894770
Clin Cancer Res. 2007 Sep 15;13(18 Pt 2):5556s-5563s
pubmed: 17875789
J Immunol. 2014 Jun 1;192(11):5273-84
pubmed: 24760155
J Clin Oncol. 2008 Sep 1;26(25):4124-30
pubmed: 18626005
Leukemia. 2018 Sep;32(9):1994-2007
pubmed: 29588546
Blood. 2006 Jun 15;107(12):4807-16
pubmed: 16484589
Front Biosci (Schol Ed). 2015 Jun 01;7:260-8
pubmed: 25961701
Blood. 2013 Oct 10;122(15):2683-93
pubmed: 24004669
Oncotarget. 2015 Feb 28;6(6):3507-18
pubmed: 25784650
FEBS Lett. 2009 Sep 3;583(17):2749-57
pubmed: 19665027
Blood. 2004 Dec 1;104(12):3705-11
pubmed: 15297317
Br J Haematol. 2007 Aug;138(4):506-12
pubmed: 17659054
Cell Rep. 2016 Oct 4;17(2):596-608
pubmed: 27705804
Cancer Immunol Immunother. 2008 Mar;57(3):389-98
pubmed: 17724589
Immunology. 1999 Oct;98(2):296-302
pubmed: 10540230
J Leukoc Biol. 2006 Mar;79(3):616-27
pubmed: 16365153
J Clin Oncol. 2012 Jun 20;30(18):2190-6
pubmed: 22614995
J Immunol. 2015 Feb 15;194(4):1434-45
pubmed: 25595783
Haematologica. 2012 Apr;97(4):572-8
pubmed: 22180430
Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):562-567
pubmed: 28031488
Blood. 2004 Nov 15;104(10):3358-60
pubmed: 15297316
Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16228-33
pubmed: 20805506
Leukemia. 2009 Nov;23(11):2129-38
pubmed: 19657361
J Immunol. 2012 Jan 1;188(1):259-69
pubmed: 22140262
Oncotarget. 2018 Dec 28;9(102):37700-37714
pubmed: 30701025
Blood. 2016 May 19;127(20):2375-90
pubmed: 26980727
Blood. 2005 Dec 15;106(13):4287-93
pubmed: 16123212
Nat Commun. 2016 Jan 12;7:10087
pubmed: 26753883
Lancet. 2019 Jan 19;393(10168):229-240
pubmed: 30522922
Blood. 2011 Apr 28;117(17):4530-41
pubmed: 21228331
Blood. 2015 Jan 1;125(1):124-32
pubmed: 25359993
J Pathol Clin Res. 2019 Jan;5(1):12-24
pubmed: 30191677
Mutat Res Rev Mutat Res. 2014 Oct-Dec;762:123-32
pubmed: 25475421
J Biol Chem. 1990 Apr 5;265(10):5787-92
pubmed: 1690714
Br J Haematol. 2013 Nov;163(4):478-86
pubmed: 24112026
Int Immunol. 2004 Oct;16(10):1355-64
pubmed: 15351782
J Natl Cancer Inst. 2014 Feb;106(2):djt378
pubmed: 24491302
Cell Signal. 2011 Jan;23(1):135-44
pubmed: 20807568
Crit Rev Oncol Hematol. 2013 Feb;85(2):206-15
pubmed: 22789917
Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5831-6
pubmed: 19321746
J Biol Chem. 2008 Feb 1;283(5):2784-92
pubmed: 18056708
J Immunol. 2010 Aug 15;185(4):2020-31
pubmed: 20639480
Biochim Biophys Acta. 2016 Jun;1863(6 Pt A):1269-81
pubmed: 27033518
Blood. 2011 Jan 20;117(3):915-9
pubmed: 21030553

Auteurs

Kathrin D Wurster (KD)

Max-Delbrück-Center (MDC) for Molecular Medicine, 13125 Berlin, Germany.
Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12200 Berlin, Germany.
Experimental and Clinical Research Center, a joint cooperation between the Charité and the MDC, 13125 Berlin, Germany.

Mariantonia Costanza (M)

Max-Delbrück-Center (MDC) for Molecular Medicine, 13125 Berlin, Germany.
Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12200 Berlin, Germany.
Experimental and Clinical Research Center, a joint cooperation between the Charité and the MDC, 13125 Berlin, Germany.

Stephan Kreher (S)

Max-Delbrück-Center (MDC) for Molecular Medicine, 13125 Berlin, Germany.
Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12200 Berlin, Germany.
Experimental and Clinical Research Center, a joint cooperation between the Charité and the MDC, 13125 Berlin, Germany.

Selina Glaser (S)

Institute of Human Genetics, Ulm University, Ulm University Medical Center, 89081 Ulm, Germany.

Björn Lamprecht (B)

Max-Delbrück-Center (MDC) for Molecular Medicine, 13125 Berlin, Germany.
Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12200 Berlin, Germany.
Experimental and Clinical Research Center, a joint cooperation between the Charité and the MDC, 13125 Berlin, Germany.
German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Nikolai Schleussner (N)

Max-Delbrück-Center (MDC) for Molecular Medicine, 13125 Berlin, Germany.
Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12200 Berlin, Germany.
Experimental and Clinical Research Center, a joint cooperation between the Charité and the MDC, 13125 Berlin, Germany.

Ioannis Anagnostopoulos (I)

Institute of Pathology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.

Michael Hummel (M)

German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Institute of Pathology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.

Korinna Jöhrens (K)

Institute of Pathology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.

Harald Stein (H)

Pathodiagnostik Berlin, 12099 Berlin, Germany.

Arturo Molina (A)

Sutro Biopharma, South San Francisco, CA 94080, USA.

Arjan Diepstra (A)

Department of Pathology and Medical Biology, University of Groningen, University Medical Centre Groningen, 9700 RB Groningen, The Netherlands.

Bernd Gillissen (B)

Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, 13125 Berlin, Germany.

Karl Köchert (K)

Max-Delbrück-Center (MDC) for Molecular Medicine, 13125 Berlin, Germany.
Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12200 Berlin, Germany.
Experimental and Clinical Research Center, a joint cooperation between the Charité and the MDC, 13125 Berlin, Germany.

Reiner Siebert (R)

Institute of Human Genetics, Ulm University, Ulm University Medical Center, 89081 Ulm, Germany.

Olaf Merkel (O)

Unit of Experimental and Laboratory Animal Pathology, Department of Pathology, Medical University of Vienna, 1090 Vienna, Austria.
European Research Initiative on ALK-related malignancies (ERIA), 1090 Vienna, Austria.

Lukas Kenner (L)

Unit of Experimental and Laboratory Animal Pathology, Department of Pathology, Medical University of Vienna, 1090 Vienna, Austria.
European Research Initiative on ALK-related malignancies (ERIA), 1090 Vienna, Austria.

Martin Janz (M)

Max-Delbrück-Center (MDC) for Molecular Medicine, 13125 Berlin, Germany.
Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12200 Berlin, Germany.
Experimental and Clinical Research Center, a joint cooperation between the Charité and the MDC, 13125 Berlin, Germany.

Stephan Mathas (S)

Max-Delbrück-Center (MDC) for Molecular Medicine, 13125 Berlin, Germany.
Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 12200 Berlin, Germany.
Experimental and Clinical Research Center, a joint cooperation between the Charité and the MDC, 13125 Berlin, Germany.
German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
European Research Initiative on ALK-related malignancies (ERIA), 1090 Vienna, Austria.

Classifications MeSH